Chemoinformaics analysis of CIS-3-HEXEN-1-YL-ACETATE
Molecular Weight | 142.198 | nRot | 4 |
Heavy Atom Molecular Weight | 128.086 | nRig | 2 |
Exact Molecular Weight | 142.099 | nRing | 0 |
Solubility: LogS | -1.83 | nHRing | 0 |
Solubility: LogP | 2.41 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 24.2991 |
nHD | 0 | BPOL | 16.6489 |
QED | 0.34 |
Synth | 2.404 |
Natural Product Likeliness | 1.788 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.007 |
HIA | 0.003 |
CACO-2 | -4.182 |
MDCK | 0.000038 |
BBB | 0.98 |
PPB | 0.271205 |
VDSS | 0.9 |
FU | 0.691325 |
CYP1A2-inh | 0.889 |
CYP1A2-sub | 0.127 |
CYP2c19-inh | 0.218 |
CYP2c19-sub | 0.499 |
CYP2c9-inh | 0.034 |
CYP2c9-sub | 0.613 |
CYP2d6-inh | 0.029 |
CYP2d6-sub | 0.28 |
CYP3a4-inh | 0.054 |
CYP3a4-sub | 0.234 |
CL | 7.795 |
T12 | 0.784 |
hERG | 0.025 |
Ames | 0.054 |
ROA | 0.011 |
SkinSen | 0.914 |
Carcinogencity | 0.748 |
EI | 0.993 |
Respiratory | 0.056 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.950314 |